October 31, 2022
LaTonya Hickson, M.D.: Seeking a cellular therapy for chronic kidney disease
Every year, more than 130,000 people in the U.S. are diagnosed with end-stage kidney disease, with most cases caused by diabetes. Newer therapies show promise to slow kidney failure rates, but none stop progression to end-stage kidney failure. The research goal of LaTonya Hickson, M.D., is to develop a cell-based therapy that slows — or […]
Tags: Center for Regenerative Biotherapeutics, chronic kidney disease, diabetic kidney disease, end-stage kidney disease, LaTonya Hickson, nephrology, stem cell research
October 17, 2022
Stem cells show therapeutic hope for chronic lung rejection
Stem cells show potential to safely slow progression of organ rejection in some lung transplant recipients, according to early Mayo Clinic research. This discovery offers hope of one day providing a cellular therapeutic to extend the lives of patients who would not qualify for a second lung transplant after organ rejection. The research team of […]
Tags: Abba Zubair, Center for Regenerative Biotherapeutics, chronic lung rejection, lung transplant, mesenchymal stem cells, Nisha Durand, stem cell research
February 1, 2022
Reimagining stem cell cultivation
Mayo Clinic has discovered how to microencapsulate pluripotent stem cells to potentially make them easier and less expensive to process and more effective for fighting disease. This research by Alexander Revzin, Ph.D., a Mayo Clinic biomedical engineer, is published in Bioactive Materials. “Human pluripotent stem cells hold considerable promise as a source of adult cellsfor […]
Tags: Alexander Revzin, biomedical engineering, Center for Regenerative Medicine, Regenerative Medicine Minnesota, stem cell research, stem cells
June 14, 2021
Mayo Clinic Research in the news — 6/14/2021
By Advancing the Science contributor
Read on for news of the week that includes Mayo Clinic Research and research experts. Topics include a new Alzheimer’s medication, COVID-19, and various regenerative medicine innovations. US approves first new Alzheimer’s drug in 20 years BBC, 6/8/2021 A controversial drug to treat Alzheimer’s disease has been approved by the Food and Drug Administration in […]
Tags: aging, Alzheimer's disease, Andre Terzic, animal model, biomedical ethics, brain, BRCA1, breast cancer, cancer, Center for Regenerative Medicine, Cheryl Willman, concussion
January 28, 2021
Regenerating the larynx: A second chance at speech
Mayo Clinic is leveraging advances in regenerative medicine to restore function for people whose lives have been drastically changed by a laryngectomy — surgery to remove the voice box. People without a voice box can neither speak with their natural voices nor breathe through their noses. Simple pleasures like smelling a bouquet of flowers or […]
Tags: 3D printing, cancer, Center for Regenerative Medicine, clinical research, clinical trials, David Lott, laryngeal cancer, laryngectomy, larynx transplant, Richard Hayden, stem cell research, stem cells
January 14, 2021
3 things to consider before preserving your stem cells
The proliferating stem cell banking industry is built on a riveting concept: Preserve stem cells while they’re most potent until they are needed later in life to potentially fight disease. What started out as a market for banking stem cells from a baby’s umbilical cord blood and tissue is mushrooming into an industry that now […]
Tags: Andre Terzic, biobank, bioethics, biomedical ethics, Center for Regenerative Medicine, stem cell research, stem cell therapy, stem cells, Zubin Master
January 6, 2021
Diverse ways regenerative medicine is advancing health care
Regenerative medicine has contributed to patient care in 2020 more than ever before, bolstered by synergies in research, practice and education. Mayo Clinic’s Center for Regenerative Medicine is at the forefront of a biotherapy revolution in which health care advances from treating disease to restoring health. “The centrality of the body to regenerate itself is […]
Tags: 3D printing, Andre Terzic, artificial intelligence, Atta Behfar, autoimmune disorder, biomedical engineering, CAR-T cell therapy, Center for Regenerative Medicine, clinical research, clinical trials, data science, fetal surgery
November 6, 2020
Long-term safety, benefits of stem cell therapy for heart failure
The largest regenerative medicine clinical trial to date for heart failure finds stem cell therapy is safe over the long term and benefits patients with advanced left ventricular enlargement. This multinational research, co-led by Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine, and published in ESC Heart Failure, offers guidance in […]
Tags: Andre Terzic, cardiovascular disease, Center for Regenerative Medicine, clinical research, clinical trials, heart failure, stem cell research, stem cell therapy
September 22, 2020
Regenerative Medicine Biotrust: advancing the practice through research
Regenerative medicine is a catalyst for innovation in health care, shifting the focus from treating symptoms of disease to unleashing the body’s ability to heal. Integral to the Mayo Clinic Center for Regenerative Medicine, the Center for Regenerative Medicine Biotrust is an important investment for Mayo Clinic. This unique resource enables physicians and scientists to […]
Tags: Center for Regenerative Medicine, Dennis Wigle, induced pluripotent stem cells, Michael Ackerman, regenerative sciences, stem cell research, Zachary Resch
September 8, 2020
Stem cell research to improve hemodialysis
Stem cell therapy after angioplasty helps keep arteriovenous fistula blood vessels open, Mayo Clinic discovered in animal studies. An arteriovenous fistula is a passageway between an artery and a vein. This research, supported in part by the Mayo Clinic Center for Regenerative Medicine, provides a foundation on which someday patients with end stage renal disease, who […]
Tags: angioplasty, Center for Regenerative Medicine, dialysis, hemodialysis, kidney disease, medical research, nephrology, Sanjay Misra, stem cell research